MedTrace Logo

Efficacy and Safety Study of Prucalopride for the Re-Treatment of Chronic Constipation

NCT00598338 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 516

Last updated 2008-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether prucalopride is safe and effective in the re-treatment of chronic constipation.

Hypothesis:

Retreatment is as effective and safe as treatment with prucalopride in patients with chronic constipation.

Conditions

Interventions

DRUG

Prucalopride

4 mg o.d.

OTHER

Placebo

o.d.

Sponsors & Collaborators

  • Movetis

    lead INDUSTRY

Principal Investigators

  • Miner, Jr. B Miner, MD · Oklahoma Foundation for Digestive Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-04-30
Primary Completion
2000-02-29
Completion
2000-02-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00598338 on ClinicalTrials.gov